Delayed Antibody Treatment May Improve Efficacy of mRNA Vaccines

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.feinberg.northwestern.edu/2024/10/28/delayed-antibody-treatment-may-improve-efficacy-of-mrna-vaccines/
Research Institution
Northwestern University Feinberg School of Medicine
Short Title
Delayed Antibody Treatment May Improve Efficacy of mRNA Vaccines
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh

Maternal Antibodies Interfere with Malaria Vaccine Responses

Fiocruz Will Lead the First Clinical Trial of a Leprosy Vaccine in Brazil

Duke Human Vaccine Institute to Develop Avian Flu Vaccine Protecting Against Variants, Provide Long-Lasting Immunity

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.dukechronicle.com/article/2024/10/duke-university-duke-human-vaccine-institute-new-vaccine-h5n1-avian-flu-strains-immunity-7-million-dollar-grant
Research Institution
Duke Human Vaccine Institute
Short Title
Duke Human Vaccine Institute to Develop Avian Flu Vaccine Protecting Against Variants, Provide Long-Lasting Immunity
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh

Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines

The identification of T cell epitopes is a critical step in understanding the immune response to infection and in designing vaccine-based approaches. Here the authors introduce a framework of antigen discovery called MHCvalidator and Epitrack to identify new antigenic features for T-cell COVID-19 vaccines and characterize a novel non-canonical epitope from a truncated Spike variant and mutation of an immunodominant epitope in the BNT162b4 vaccine.

Link Type
Data-Sci-Publications
Publish or Event Date
Link URL
https://pmc.ncbi.nlm.nih.gov/articles/PMC11604954/
Short Title
Machine learning-enhanced immunopeptidomics applied to
Content Coordinator
Lisa Mayer
Content Manager
Reed Shabman
Publication Source

Nature Communications

Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study

Acute kidney injury (AKI) has been noticed after both COVID-19 vaccination and infection. The authors used data from the National COVID Cohort Collaborative (N3C) dataset to compare AKI incidence following COVID-19 vaccination and infection, revealing that COVID-19 vaccination is associated with a significant lower AKI risk compared to COVID-19 infection.

Link Type
Data-Sci-Publications
Publish or Event Date
Link URL
https://pmc.ncbi.nlm.nih.gov/articles/PMC11549351/
Short Title
Assessing acute kidney injury risk after COVID vaccination
Content Coordinator
Lisa Mayer
Content Manager
Reed Shabman
Publication Source

NPJ Vaccines

NIH Statement on World AIDS Day

Together with our partners, the National Institutes of Health (NIH) commemorates World AIDS Day and affirms our commitment to bolstering the extraordinary gains achieved in HIV science and to persevering until we end HIV-related illness and stigma. As we mark this observance, we celebrate the people who enable scientific progress, honor the loved ones and leaders we have lost, and reflect on the work that remains to ensure the health and life quality of all people affected by, and living with, HIV.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

CAHNR Researcher Wins $3.8 Million NIH Grant to Develop Leptospirosis Vaccine

NIH Awards UAMS $3.7 Million in Quest for More Effective Tuberculosis Vaccine

Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium

Subscribe to Vaccines